Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine versus ropivacaine local infiltration analgesia after total knee arthroplasty
ChiCTR2400087622Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jul 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative pain comparing Traditional ropivacaine cocktail local infiltration with Liposomal bupivacaine local infiltration (2 arms). Primary endpoints: Postoperative dosage of remedial morphine hydrochloride, Time to first postoperative remedial analgesia and 1 more. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
bupivacaineropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2400087622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400087622.